Different Patterns of Cytokines and Chemokines Combined with IFN-γ Production Reflect Mycobacterium tuberculosis Infection and Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Yu, Yang ^a   Zhang, Yan ^a   Hu, Shizong ^a   Jin, Dongdong ^a   Chen, Xinchun ^b   Jin, Qi ^a   Liu, Haiying ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE; CXCL11 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ALPHA; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MYCOBACTERIUM ANTIGEN; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CHINA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; LUNG CANCER; LUNG TUBERCULOSIS; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL FLUID MONONUCLEAR CELL; PLEURA EFFUSION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TUBERCULOUS PLEURISY;

ADULT; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CHEMOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84866428962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044944     Document Type: Article

References (56)

1. WHO (2010) Report: Global tuberculosis control.
2. WHO (2008) Report: Stop TB Partnership.
3. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, et al. (2001) Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 167: 5217-5225.
4. Sia IG, Wieland ML, (2011) Current concepts in the management of tuberculosis. Mayo Clin Proc 86: 348-361.
5. Warier A, Gunawathi S, Venkatesh, John KR, Bose A, (2010) T-cell assay as a diagnostic tool for tuberculosis. Indian Pediatr 47: 90-92.
6. Khatami K, (2002) Pleural Tuberculosis. Shiraz E Medical Journal 3: 78-86.
7. Kaufmann SH, (2001) How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 1: 20-30.
8. Maglione PJ, Chan J, (2009) How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 39: 676-686.
9. Ferrara G, Losi M, Fabbri LM, Migliori GB, Richeldi L, et al. (2009) Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. Arch Immunol Ther Exp (Warsz) 57: 425-433.
10. Chen X, Yang Q, Zhang M, Graner M, Zhu X, et al. (2009) Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 16: 879-884.
11. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A, (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
12. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, et al. (2010) Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 40: 2211-2220.
13. Djoba Siawaya JF, Chegou NN, van den Heuvel MM, Diacon AH, Beyers N, et al. (2009) Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 47: 132-136.
14. Nolen BM, Marks JR, Ta'san S, Rand A, Luong TM, et al. (2008) Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res 10: R45.
15. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, et al. (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69: 570-580.
16. Chen X, Zhang M, Zhu X, Deng Q, Liu H, et al. (2009) Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy. J Infect Dis 200: 399-408.
17. Qiu Z, Zhang M, Zhu Y, Zheng F, Lu P, et al. (2012) Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep 2: 216.
18. Chen X, Zhang M, Liao M, Graner MW, Wu C, et al. (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 181: 734-742.
19. Louis KS, Siegel AC, (2011) Cell viability analysis using trypan blue: manual and automated methods. Methods Mol Biol 740: 7-12.
20. Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol Chapter 7: Unit7 1.
21. Kanof ME, Smith PD, Zola H (2001) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol Chapter 7: Unit 7 1.
22. Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, et al. (2009) Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 9: 99.
23. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, et al. (2008) Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128: 2640-2645.
24. Guimaraes T (2012) Evaluation of the Immune Response of Individuals Infected with Mycobacterium tuberculosis and Patients with Active Tuberculosis. ISRN Immunology 2012.
25. Chen X, Zhang M, Liao M, Graner MW, Wu C, et al. (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 181: 734-742.
26. Liu K, Zhang Y, Hu S, Yu Y, Yang Q, et al. (2012) Increased Levels of BAFF and APRIL Related to Human Active Pulmonary Tuberculosis. PLoS ONE 7.
27. Pai M (2010) Spectrum of latent tuberculosis- existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 8: 242; author reply 242.
28. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174: 349-355.
29. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192.
30. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, et al. (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831-839.
31. Lu C, Wu J, Wang H, Wang S, Diao N, et al. (2011) Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One 6: e24290.
32. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, et al. (2007) Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol 178: 3688-3694.
33. Zhang S, Shao L, Mo L, Chen J, Wang F, et al. (2010) Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations. Clin Vaccine Immunol 17: 1985-1990.
34. Cooper AM, (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393-422.
35. Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y, (2010) The immunology of tuberculosis: from bench to bedside. Respirology 15: 433-450.
36. Wilkinson KA, Wilkinson RJ, (2010) Polyfunctional T cells in human tuberculosis. Eur J Immunol 40: 2139-2142.
37. Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, et al. (2010) Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 375: 2179-2191.
38. Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, et al. (2011) Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin Immunol 138: 50-59.
39. Saunders BM, Frank AA, Orme IM, Cooper AM, (2000) Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 68: 3322-3326.
40. Tsao TC, Hong J, Huang C, Yang P, Liao SK, et al. (1999) Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis 79: 279-285.
41. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, et al. (2008) IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol 126: 202-210.
42. Herrera MT, Torres M, Nevels D, Perez-Redondo CN, Ellner JJ, et al. (2009) Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis. Tuberculosis (Edinb) 89: 38-47.
43. Seibert AF, Haynes J Jr, Middleton R, Bass JB Jr, (1991) Tuberculous pleural effusion. Twenty-year experience. Chest 99: 883-886.
44. Villegas MV, Labrada LA, Saravia NG, (2000) Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 118: 1355-1364.
45. McGrath EE, Anderson PB, (2010) Diagnostic tests for tuberculous pleural effusion. Eur J Clin Microbiol Infect Dis 29: 1187-1193.
46. Wu SH, Li CT, Lin CH, Chu JJ, Cheng ML, et al. (2010) Soluble Fas ligand is another good diagnostic marker for tuberculous pleurisy. Diagn Microbiol Infect Dis 68: 395-400.
47. Yoshie O, Imai T, Nomiyama H, (2001) Chemokines in immunity. Adv Immunol 78: 57-110.
48. Zlotnik A, Yoshie O, (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
49. Hasan Z, Jamil B, Ashraf M, Islam M, Yusuf MS, et al. (2009) ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS One 4: e5158.
50. Jo EK, Park JK, Dockrell HM, (2003) Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 16: 205-210.
51. Kurashima K, Mukaida N, Fujimura M, Yasui M, Nakazumi Y, et al. (1997) Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 155: 1474-1477.
52. Mohammed KA, Nasreen N, Ward MJ, Mubarak KK, Rodriguez-Panadero F, et al. (1998) Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy. J Infect Dis 178: 1450-1456.
53. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, et al. (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32: 1607-1615.
54. Supriya P, Chandrasekaran P, Das SD, (2008) Diagnostic utility of interferon-gamma-induced protein of 10 kDa (IP-10) in tuberculous pleurisy. Diagn Microbiol Infect Dis 62: 186-192.
55. Schreiber T, Ehlers S, Aly S, Holscher A, Hartmann S, et al. (2006) Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol 176: 1131-1140.
56. Pokkali S, Das SD, R L, (2008) Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 41: 307-314.